🔎 Trials Near Me

Akèy › Maladi Entestinal Anflamatwa › Texas › Houston

Etid klinik pou Maladi Entestinal Anflamatwa nan Houston, TX

8 etid pou Maladi Entestinal Anflamatwa ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 2
  • Baylor College of Medicine, Houston
  • Intergrity Research, Houston
Laj 18 a 75 · Tout sèks · Mizajou Sep 30, 2026 · NCT06598943

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

Ap rekriteFaz 1/2Volontè an sante akeyi
  • Xencor Investigative Site, Houston
  • Xencor Investigative Site, Houston
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT06619990

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 2
  • Site US-030, Houston
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07845487

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Ap rekriteFaz 1
  • UT MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 2
  • The University of Texas Health Science Center at Houston, Houston
Laj 18 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT06226883

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

Ap rekriteEtid obsèvasyon
  • M D Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou May 20, 2026 · NCT04751396

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Ap rekriteFaz 2
  • Mirador Therapeutics Selected Site, Houston
Laj 18 a 80 · Tout sèks · Mizajou Mar 12, 2026 · NCT07113522

Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease

Ap rekrite
  • Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Laj 18 ak plis · Tout sèks · Mizajou Mar 11, 2026 · NCT07210580

Etid Maladi Entestinal Anflamatwa nan lòt vil

Lòt etid nan Houston

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.